5701 |
7YZI |
D_A |
NB4 Nanobody |
Mycobacterium tuberculosis adenylyl cyclase Rv1625c / Cya |
Mycobacterium tuberculosis '98-R604 INH-RIF-EM, Vicugna pacos |
EM |
3.83 | 10.7554/eLife.77032 |
5702 |
7YZI |
C_B |
NB4 Nanobody |
Mycobacterium tuberculosis adenylyl cyclase Rv1625c / Cya |
Mycobacterium tuberculosis '98-R604 INH-RIF-EM, Vicugna pacos |
EM |
3.83 | 10.7554/eLife.77032 |
5703 |
7YZI |
E_A |
NB4 Nanobody |
Mycobacterium tuberculosis adenylyl cyclase Rv1625c / Cya |
Mycobacterium tuberculosis '98-R604 INH-RIF-EM, Vicugna pacos |
EM |
3.83 | 10.7554/eLife.77032 |
5704 |
7YZK |
C_B |
NB4 VHH |
Mycobacterium tuberculosis adenylyl cyclase (AC) Rv1625c/Cya |
Mycobacterium tuberculosis, Vicugna pacos |
EM |
3.57 | 10.7554/eLife.77032 |
5705 |
7YZK |
D_A |
NB4 VHH |
Mycobacterium tuberculosis adenylyl cyclase (AC) Rv1625c/Cya |
Mycobacterium tuberculosis, Vicugna pacos |
EM |
3.57 | 10.7554/eLife.77032 |
5706 |
7Z12 |
BC_A |
PAM1.4 Fab |
Plasmodium falciparum polymorphic malarial protein VAR2CSA |
Homo sapiens, Plasmodium falciparum |
EM |
3 | 10.1371/journal.ppat.1010924 |
5707 |
7Z2M |
HL_I |
11.003 Fab |
Human Interleukin-17A |
Homo sapiens |
XRD |
1.9 | 10.1038/s42003-023-05369-x |
5708 |
7Z2M |
DC_G |
11.003 Fab |
Human Interleukin-17A |
Homo sapiens |
XRD |
1.9 | 10.1038/s42003-023-05369-x |
5709 |
7Z2M |
FE_J |
11.003 Fab |
Human Interleukin-17A |
Homo sapiens |
XRD |
1.9 | 10.1038/s42003-023-05369-x |
5710 |
7Z2M |
BA_K |
11.003 Fab |
Human Interleukin-17A |
Homo sapiens |
XRD |
1.9 | 10.1038/s42003-023-05369-x |
5711 |
7Z4T |
HL_I |
AAL160 Fab |
Human interleukin-1 beta |
Homo sapiens |
XRD |
3.3 | 10.1038/s42003-023-05369-x |
5712 |
7Z6V |
X_A |
H11 VHH |
SARS-CoV-2 spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Tequatrovirus T4, Lama glama |
EM |
3.1 | 10.1073/pnas.2205412119 |
5713 |
7Z6V |
Y_B |
H11 VHH |
SARS-CoV-2 spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Tequatrovirus T4, Lama glama |
EM |
3.1 | 10.1073/pnas.2205412119 |
5714 |
7Z6V |
Z_C |
H11 VHH |
SARS-CoV-2 spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Tequatrovirus T4, Lama glama |
EM |
3.1 | 10.1073/pnas.2205412119 |
5715 |
7Z7X |
D_A |
H11-H6 VHH |
SARS-CoV-2 spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Tequatrovirus T4, Lama glama |
EM |
3.3 | 10.1073/pnas.2205412119 |
5716 |
7Z7X |
E_B |
H11-H6 VHH |
SARS-CoV-2 spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Tequatrovirus T4, Lama glama |
EM |
3.3 | 10.1073/pnas.2205412119 |
5717 |
7Z7X |
F_C |
H11-H6 VHH |
SARS-CoV-2 spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Tequatrovirus T4, Lama glama |
EM |
3.3 | 10.1073/pnas.2205412119 |
5718 |
7Z85 |
D_A |
H11-B5 VHH |
SARS-CoV-2 spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Tequatrovirus T4, Lama glama |
EM |
3.1 | 10.1073/pnas.2205412119 |
5719 |
7Z85 |
E_B |
H11-B5 VHH |
SARS-CoV-2 spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Tequatrovirus T4, Lama glama |
EM |
3.1 | 10.1073/pnas.2205412119 |
5720 |
7Z85 |
F_C |
H11-B5 VHH |
SARS-CoV-2 spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Tequatrovirus T4, Lama glama |
EM |
3.1 | 10.1073/pnas.2205412119 |